Bristol-Myers Squibb Q4 Earnings: Pharma Giant Bets Big on Next-Generation Drug Pipeline
Bristol-Myers Squibb reports Q4 2025 earnings with analysts focused on new drug approvals and the transition beyond legacy blockbusters like Opdivo and Eliquis.
TRENDING TOPICS
3286 articles found for "investing"
Bristol-Myers Squibb reports Q4 2025 earnings with analysts focused on new drug approvals and the transition beyond legacy blockbusters like Opdivo and Eliquis.
Bitcoin falls to its lowest level since November 2024 as the cryptocurrency market sheds $467 billion in value amid risk-off sentiment and regulatory uncertainty.
Healthcare stocks surge as investors flee technology chaos, with the sector posting its best relative performance since 2022 as Amgen, Merck, and UnitedHealth lead the defensive rally.
Legendary investor Ray Dalio warns at World Governments Summit that geopolitical tensions could weaponize money through trade embargoes and capital controls. Gold remains his top hedge.
Bitcoin clawed back 5% to the high $78,000s on Tuesday as oversold conditions triggered institutional buying. Bitwise executives predict Bitcoin could reach $1 million over the next decade.
Walmart becomes the first traditional retailer to reach $1 trillion market cap, joining tech giants Nvidia, Apple, and Amazon in the elite valuation club.
As enterprise software stocks crater on AI disruption fears, cybersecurity leaders CrowdStrike and Palo Alto Networks are outperforming. Here's why security remains the exception.
Costco's Executive membership signups are running 2-3 times higher than total membership growth as the retailer captures affluent trade-down shoppers.
The Consumer Staples Select Sector SPDR Fund posts its best short-term performance since 2022 as investors rotate from high-growth tech into defensive stocks.
Merck delivered strong Q4 2025 results on Keytruda demand, but 2026 guidance disappointed investors as the pharmaceutical giant prepares for patent cliff challenges.
The Russell 2000 has surged 6% in 2026 while the S&P 500 gains just 1.2%, marking the beginning of what Wall Street calls the 'Great Rotation' into small-cap stocks.
The longest yield curve inversion in financial history has ended without producing a recession, as the NY Fed puts recession probability at just 27% and falling.